Statins and hepatotoxicity

This publication has 43 references indexed in Scilit:

• Patients with Elevated Baseline Liver Enzymes Do Not Have Higher Frequency of Hepatotoxicity from Lovastatin than Those with Normal Baseline Liver Enzymes
  The Lancet Healthy Longevity, 2005
• Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity
  Gastroenterology, 2004
• Statins and Liver Toxicity: A Meta‐Analysis
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2004
• Hepatotoxicity of hypolipidemic drugs
  Clinics in Liver Disease, 2003
• The New National Cholesterol Education Program Guidelines
  Archives of internal medicine (1960), 2002
• ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins
  Circulation, 2002
• Safety and Tolerability of Pravastatin in Long-Term Clinical Trials
  Circulation, 2002
• Comparative Tolerability of the HMG-CoA Reductase Inhibitors
  Drug Safety, 2000
• Biochemical Changes and Morphological Alterations of the Liver in Guinea‐Pigs after Administration of Simvastatin (HMG CoA Reductase‐Inhibitor)
  Basic & Clinical Pharmacology & Toxicology, 1990
• Preclinical evaluation of lovastatin
  The American Journal of Cardiology, 1988